Bugworks Research India Pvt Ltd
Karnataka
Est. 2014
About Company
Description
Antibiotic biotech development
Contact Information
Primary Phone
Primary Email
Website
Registered Address
State
Karnataka
Country
India
Business Information
Business Types
Manufacturer
API Supplier
Year Established
2014
Manufacturing Units
1
Legal & Compliance
Certifications & Approvals
WHO-GMP
Not Certified
ISO
Certified
GMP
Not Certified
FSSAI
Not Certified
USFDA
Not Approved
EU-GMP
Not Certified
UK-MHRA
Not Approved
WHO Prequalified
No
PCD/Franchise Information
PCD Franchisor
No
Products
Total products: 18
| Product Name | Dosage Form | Composition | Therapeutic Category |
|---|---|---|---|
| (9-isopropyl-9-azabicyclo[3,3,1]non-3-yl)methanol | - | IPRATROPIUM BROMIDE | - |
| (9-isopropyl-9-azabicyclo[3,3,1]non-3-yl)methanol | - | IPRATROPIUM BROMIDE | - |
| 4-Oxo-2-Phenylbutanoic acid | - | IPRATROPIUM BROMIDE | - |
| 4-Oxo-2-Phenylbutanoic acid | - | IPRATROPIUM BROMIDE | - |
| An article featuring remarks by Dr. Vasan Sambandamurthy underscores the critical necessity for the development of novel antibiotics. November 14, 2025 Published in The Hindu | - | - | Antibiotics |
| An article featuring remarks by Dr. Vasan Sambandamurthy underscores the critical necessity for the development of novel antibiotics. November 14, 2025 Published in The Hindu | - | - | Antibiotics |
| Bugworks has been featured in the Future Makers series produced by Warner Bros. Discovery India, which highlights C-CAMP as Karnataka’s leading biotech innovation hub. December 14, 2025 Available on A | - | Discovery+ OTT | - |
| Bugworks has been featured in the Future Makers series produced by Warner Bros. Discovery India, which highlights C-CAMP as Karnataka’s leading biotech innovation hub. December 14, 2025 Available on A | - | Discovery+ OTT | - |
| Methyl 2, 2-dithienyl glycolate (Methyl Glycolate) | - | TIOTROPIUM BROMIDE | - |
| Methyl 2, 2-dithienyl glycolate (Methyl Glycolate) | - | TIOTROPIUM BROMIDE | - |
| MORE TABS EVENTS STATUTORY SECTION REPORT DIRECTOR REPORT EC-Approved Letter Six Monthly compliance report Six Monthly Report 6 monthly compliance report Oct 2022 to March 2023 33rd Annual Report 2022 | Tablet | - | - |
| MORE TABS EVENTS STATUTORY SECTION REPORT DIRECTOR REPORT EC-Approved Letter Six Monthly compliance report Six Monthly Report 6 monthly compliance report Oct 2022 to March 2023 33rd Annual Report 2022 | Tablet | - | - |
| N-Isopropyl Noratropine (IPT-II) | - | IPRATROPIUM BROMIDE | - |
| N-Isopropyl Noratropine (IPT-II) | - | IPRATROPIUM BROMIDE | - |
| Scopine-DI, 2-dithienyl glycolate (Scopine ester) | - | TIOTROPIUM BROMIDE | - |
| Scopine-DI, 2-dithienyl glycolate (Scopine ester) | - | TIOTROPIUM BROMIDE | - |
| The article “Grit, Gamble and a Giant Drug Discovery: Inside Habil Khorakiwala’s Bold Rebuild of Wockhardt and Indian Pharma” features remarks by Leela Maitreyi, which underscore the critical need to | - | - | Antibiotics |
| The article “Grit, Gamble and a Giant Drug Discovery: Inside Habil Khorakiwala’s Bold Rebuild of Wockhardt and Indian Pharma” features remarks by Leela Maitreyi, which underscore the critical need to | - | - | Antibiotics |
Social Media
Company Status
Status
Active
Verification
Verified
Statistics
Profile Views
63
Total Inquiries
0